retatrutide clinical trial data Safety, Side Effects & Provider Use Retatrutide Phase 3: TRIUMPH Program
Description
You might feel the need to urinate far more often than usual, and when the urge strikes, it feels impossible to wait
GLP-1 receptor agonists slow gastric emptying and reduce appetite, which can lead to altered eating patterns, reduced caloric intake, and potential nutritional imbalances during the adjustment period
This information is educational and does not replace professional medical advice
Warning signs include spreading redness, warmth, pus, fever, and worsening pain
Each functions through the GLP-1 pathways to curb appetite, enhance satiety, and promote sustainable weight loss
